FIRMAGON® is a unique hormone therapy that treats advanced prostate
cancer. It is called a GnRH receptor antagonist or blocker and works by
blocking the production of gonadotropin-releasing hormone (GnRH) by the
pituitary gland. GnRH stimulates the testes to produce testosterone.
Testosterone affects the growth of the prostate gland and any cancer
cells that may be present. By blocking GnRH, FIRMAGON® reduces the
body's level of testosterone.
Animation by: Omar Momani and Sameer Timoshenko Aburezeq
Tweet
Follow @omomani
Animation by: Omar Momani and Sameer Timoshenko Aburezeq